Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells
Open Access
- 26 April 2012
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 5 (5) , 405-416
Abstract
A simple method for attaching immunoglobulin G (IgG) on the cell surface was successfully developed for enhancing phagocytosis of apoptotic tumor cells (ATCs) by dendritic cells (DCs) ex vivo. By conjugating with a poly(ethylene glycol) (PEG)-lipid, named the biocompatible anchor for the membrane (BAM), arbitrary IgG could be incorporated into the cell membrane. In particular, when IgG-BAM conjugates were prepared at the optimal molar ratio of IgG to BAM (1 to 20), almost all cells were efficiently modified with IgG by treatment with IgG-BAM. This simple method was successfully applied to four types of mammalian cells. Furthermore, treatment of ATCs with the IgG-BAM conjugate increased the phagocytosis ratio of ATCs by DCs two-fold when compared to no treatment. This phagocytosis-enhancing effect was nearly identical to treatment with a tumor-specific IgG. Thus, without employing the tumor-specific IgG, which is difficult to obtain for any tumor cells and is expensive, the present method could opsonize ATC with the use of arbitrary IgG. The results strongly indicate that IgG-BAM treatment represents a promising method for opsonizing ATC with human serum IgG, and that this approach will lead to objective clinical responses in DC vaccines.Keywords
This publication has 29 references indexed in Scilit:
- Therapeutic antibodies for autoimmunity and inflammationNature Reviews Immunology, 2010
- Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosisBritish Journal of Cancer, 2009
- Surface Modification of Islets With PEG-Lipid for Improvement of Graft Survival in Intraportal TransplantationTransplantation, 2009
- Modulating the Actions of NK Cell-Mediated Cytotoxicity Using Lipid-PEG (n) and Inhibitory Receptor-Specific Antagonistic Peptide ConjugatesBiotechnology Progress, 2008
- Dendritic-cell-based therapeutic vaccination against cancerCurrent Opinion in Immunology, 2005
- Dendritic cells as therapeutic vaccines against cancerNature Reviews Immunology, 2005
- The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular CytotoxicityJournal of Biological Chemistry, 2003
- IgG Fc ReceptorsAnnual Review of Immunology, 2001
- UPTAKE AND INTRACELLULAR PROCESSING OF PEG-LIPOSOMES AND PEG-IMMUNOLIPOSOMES BY KUPFFER CELLS IN VITRO*Journal of Liposome Research, 2001
- Physicochemical and biological properties of poly(ethylene glycol)-coupled immunoglobuling GBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1984